Enveric Biosciences initiated an at-the-market offering agreement with H.C. Wainwright & Co. to sell up to $2.425 million in common shares. The offering provides the company with flexible capital raising capabilities through registered securities.
Enveric Biosciences initiated an at-the-market offering agreement with H.C. Wainwright & Co. to sell up to $2.425 million in common shares. The offering provides the company with flexible capital raising capabilities through registered securities.